Louis Edward Tamayo, Chief Financial Officer at Lexeo Therapeutics, Inc. (LXEO), sold 4,641 shares at $4.49 ($21K) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Open-market sale of $21k LXEO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.